147 related articles for article (PubMed ID: 30702570)
1. Falsely elevated thyroglobulin and calcitonin due to rheumatoid factor in non-relapsing thyroid carcinoma: A case report.
Lupoli GA; Barba L; Liotti A; La Civita E; Lupoli R; Riccio E; Portella G; Formisano P; Beguinot F; Terracciano D
Medicine (Baltimore); 2019 Feb; 98(5):e14178. PubMed ID: 30702570
[TBL] [Abstract][Full Text] [Related]
2. A rare case report of very low thyroglobulin and a negative whole-body scan in a patient with a solid variant of papillary thyroid carcinoma with distant metastases.
Li W; Sun D; Ming H; Zhang G; Tan J
Medicine (Baltimore); 2017 Feb; 96(7):e6086. PubMed ID: 28207517
[TBL] [Abstract][Full Text] [Related]
3. Markedly elevated serum thyroglobulin associated with heterophile antibodies: a cautionary tale.
Ding L; Shankara-Narayana N; Wood C; Ward P; Sidhu S; Clifton-Bligh R
Thyroid; 2013 Jun; 23(6):771-2. PubMed ID: 23294194
[No Abstract] [Full Text] [Related]
4. Multiple immunoassay interference in a patient with falsely elevated calcitonin.
Unal MC; Bayraktar AC; Uslu T; Yener S
Arch Endocrinol Metab; 2023 Nov; 68():e230074. PubMed ID: 37988668
[TBL] [Abstract][Full Text] [Related]
5. Clinical Impact of Detectable Antithyroglobulin Antibodies Below the Reference Limit (Borderline) in Patients with Papillary Thyroid Carcinoma with Undetectable Serum Thyroglobulin and Normal Neck Ultrasonography After Ablation: A Prospective Study.
Côrtes MCS; Rosario PW; Oliveira LFF; Calsolari MR
Thyroid; 2018 Feb; 28(2):229-235. PubMed ID: 29325506
[TBL] [Abstract][Full Text] [Related]
6. Heterophile antibodies may falsely increase or decrease thyroglobulin measurement in patients with differentiated thyroid carcinoma.
Giovanella L; Keller F; Ceriani L; Tozzoli R
Clin Chem Lab Med; 2009; 47(8):952-4. PubMed ID: 19589101
[TBL] [Abstract][Full Text] [Related]
7. Phantoms in the assay tube: heterophile antibody interferences in serum thyroglobulin assays.
Preissner CM; O'Kane DJ; Singh RJ; Morris JC; Grebe SK
J Clin Endocrinol Metab; 2003 Jul; 88(7):3069-74. PubMed ID: 12843145
[TBL] [Abstract][Full Text] [Related]
8. Predictive Value of Serum Thyroglobulin for Structural Recurrence Following Lobectomy for Papillary Thyroid Carcinoma.
Xu S; Huang H; Zhang X; Huang Y; Guan B; Qian J; Wang X; Liu S; Xu Z; Liu J
Thyroid; 2021 Sep; 31(9):1391-1399. PubMed ID: 34340593
[No Abstract] [Full Text] [Related]
9. Heterophile antibodies rarely influence the measurement of thyroglobulin and thyroglobulin antibodies in differentiated thyroid cancer patients.
Verburg FA; Wäschle K; Reiners C; Giovanella L; Lentjes EG
Horm Metab Res; 2010 Sep; 42(10):736-9. PubMed ID: 20486066
[TBL] [Abstract][Full Text] [Related]
10. False positive in the measurement of thyroglobulin induced by rheumatoid factor.
Astarita G; Gutiérrez S; Kogovsek N; Mormandi E; Otero P; Calabrese C; Alcaraz G; Vázquez A; Abalovich M
Clin Chim Acta; 2015 Jul; 447():43-6. PubMed ID: 25979693
[TBL] [Abstract][Full Text] [Related]
11. Papillary Thyroid Carcinoma Recurrence: Low Yield of Neck Ultrasound With an Undetectable Serum Thyroglobulin Level.
Epstein S; McEachern R; Khot R; Padia S; Patrie JT; Itri JN
J Ultrasound Med; 2018 Oct; 37(10):2325-2331. PubMed ID: 29498418
[TBL] [Abstract][Full Text] [Related]
12. False diagnosis of recurrent thyroid carcinoma: the importance of testing for heterophile antibodies.
Guastapaglia L; Chiamolera MI; Viana Lima Junior J; Ferrer CMF; Godoy Viana L; Veiga Chang C; Andrade Siqueira R; Monteiro Barros Maciel R; Henriques Vieira JG; Biscolla RPM
Arch Endocrinol Metab; 2024 Mar; 68():e230115. PubMed ID: 38456952
[TBL] [Abstract][Full Text] [Related]
13. Undetectable thyroglobulin after total thyroidectomy in patients with low- and intermediate-risk papillary thyroid cancer--is there a need for radioactive iodine therapy?
Ibrahimpasic T; Nixon IJ; Palmer FL; Whitcher MM; Tuttle RM; Shaha A; Patel SG; Shah JP; Ganly I
Surgery; 2012 Dec; 152(6):1096-105. PubMed ID: 23158181
[TBL] [Abstract][Full Text] [Related]
14. Prognostic impact of serum thyroglobulin doubling-time under thyrotropin suppression in patients with papillary thyroid carcinoma who underwent total thyroidectomy.
Miyauchi A; Kudo T; Miya A; Kobayashi K; Ito Y; Takamura Y; Higashiyama T; Fukushima M; Kihara M; Inoue H; Tomoda C; Yabuta T; Masuoka H
Thyroid; 2011 Jul; 21(7):707-16. PubMed ID: 21649472
[TBL] [Abstract][Full Text] [Related]
15. Significance of Low Levels of Thyroglobulin Autoantibodies Associated with Undetectable Thyroglobulin After Thyroidectomy for Differentiated Thyroid Carcinoma.
Latrofa F; Ricci D; Sisti E; Piaggi P; Nencetti C; Marinò M; Vitti P
Thyroid; 2016 Jun; 26(6):798-806. PubMed ID: 27020734
[TBL] [Abstract][Full Text] [Related]
16. Comparison between a new thyroglobulin assay with the well-established Beckman Access immunoassay: A preliminary report.
Cennamo M; La Civita E; Curci A; Liotti A; Braschi U; Terracciano D
J Clin Lab Anal; 2021 Feb; 35(2):e23589. PubMed ID: 32951246
[TBL] [Abstract][Full Text] [Related]
17. The need of prophylactic central lymph node dissection is controversial in terms of postoperative thyroglobulin follow-up of patients with cN0 papillary thyroid cancer.
Korkmaz MH; Öcal B; Saylam G; Çakal E; Bayır Ö; Tutal E; Tatar EÇ
Langenbecks Arch Surg; 2017 Mar; 402(2):235-242. PubMed ID: 28224278
[TBL] [Abstract][Full Text] [Related]
18. Preoperative undetectable serum thyroglobulin in differentiated thyroid carcinoma: incidence, causes and management strategy.
Giovanella L; Ceriani L; Ghelfo A; Maffioli M; Keller F
Clin Endocrinol (Oxf); 2007 Oct; 67(4):547-51. PubMed ID: 17561976
[TBL] [Abstract][Full Text] [Related]
19. Lowered cutoff of lymph node fine-needle aspiration thyroglobulin in thyroid cancer patients with serum anti-thyroglobulin antibody.
Jo K; Kim MH; Lim Y; Jung SL; Bae JS; Jung CK; Kang MI; Cha BY; Lim DJ
Eur J Endocrinol; 2015 Oct; 173(4):489-97. PubMed ID: 26208979
[TBL] [Abstract][Full Text] [Related]
20. Thyroid carcinoma with biphasic clinical course and evolution in medullary carcinoma-follicular variant. A case report and an immunocytochemical demonstration of calcitonin and thyroglobulin in the same neoplastic cells.
Baschieri I; Ronga G; Fiorentino A; Mariani P; Carlei F
J Nucl Med Allied Sci; 1990; 34(2):71-6. PubMed ID: 2246675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
